Olfr765, classified as an olfactory receptor (OR) in Mus musculus (house mouse), plays a crucial role in the perception of odors. As a member of the G-protein-coupled receptor (GPCR) family, Olfr765 is involved in the initial steps of olfactory signal transduction. This process begins when an odorant molecule binds to the receptor, triggering a conformational change that activates an associated G-protein. The activated G-protein then initiates a cascade of intracellular events, ultimately leading to a neuronal response that is perceived as a smell. This intricate mechanism is a part of a larger olfactory system that allows mice to detect a wide range of odorant molecules, each OR typically responding to specific odorants.
Inhibiting Olfr765, or any OR, is a complex task due to the specificity and diversity of these receptors. Direct inhibitors of individual olfactory receptors are not well-defined, primarily because the olfactory system involves a vast array of receptors, each with unique ligand specificities. Consequently, the approach to inhibition often involves indirect methods that target related pathways or processes within the olfactory signaling cascade. Given that ORs are a subset of GPCRs, compounds that modulate GPCR activity or the downstream signaling pathways can potentially influence the function of Olfr765. For instance, agents that affect the adrenergic system (e.g., beta-blockers) could indirectly impact GPCR-mediated signaling pathways, including those associated with olfactory receptors. This influence could alter the efficiency of signal transduction initiated by Olfr765, thereby modulating the olfactory response. However, the exact extent and nature of this modulation are not straightforward due to the complexity of GPCR signaling networks and the specificity of olfactory receptors. Furthermore, the indirect effects of these compounds on olfactory receptors are inferred based on their known actions on related GPCR pathways, rather than on direct evidence of interaction with ORs like Olfr765. Therefore, while these compounds present potential avenues for influencing Olfr765 activity, their precise effects on this specific receptor and the broader olfactory system remain an area of ongoing research and exploration.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Propranolol is a non-selective beta-adrenergic receptor antagonist. By blocking these receptors, it can indirectly affect GPCR signaling pathways, potentially altering the transduction efficiency of olfactory signals mediated by receptors like Olfr765. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $122.00 $235.00 $520.00 $979.00 $1500.00 | 2 | |
Carvedilol acts as a non-selective beta-adrenergic blocker with alpha-1 blocking activity. This dual action may affect downstream GPCR signaling, potentially influencing the transduction process of olfactory GPCRs such as Olfr765. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $50.00 $168.00 $520.00 | 2 | |
Yohimbine is an alpha-2 adrenergic receptor antagonist. Its action on these receptors can influence adrenergic signaling pathways, which may indirectly impact the function of GPCRs including olfactory receptors like Olfr765. | ||||||
Labetalol | 36894-69-6 | sc-484723 | 50 mg | $176.00 | ||
Labetalol combines both alpha and beta adrenergic blocking activities. This broad inhibition of adrenergic signaling could indirectly influence the signaling pathways of GPCRs, potentially affecting olfactory receptor function. | ||||||
(S)-Timolol Maleate | 26921-17-5 | sc-203297 sc-203297A | 100 mg 250 mg | $60.00 $124.00 | ||
Timolol is a beta-adrenergic receptor antagonist. Its effect on beta-adrenergic receptors can indirectly influence GPCR signaling pathways, which may affect olfactory receptor activities. | ||||||
Nadolol | 42200-33-9 | sc-253175 | 1 g | $180.00 | ||
Nadolol is a non-selective beta-adrenergic receptor antagonist. By inhibiting these receptors, it can indirectly modulate GPCR signaling pathways, which could impact the function of GPCRs like olfactory receptors. | ||||||
Sotalol hydrochloride | 959-24-0 | sc-203699 sc-203699A | 10 mg 50 mg | $67.00 $246.00 | 3 | |
Sotalol is a beta-blocker with antiarrhythmic properties. Its impact on beta-adrenergic receptors can indirectly affect GPCR signaling, which might influence the transduction process in olfactory receptors. | ||||||
Pindolol | 13523-86-9 | sc-204847 sc-204847A | 100 mg 1 g | $194.00 $760.00 | ||
Pindolol is a non-selective beta-adrenergic receptor antagonist with intrinsic sympathomimetic activity. This dual effect could indirectly modulate GPCR signaling pathways, potentially affecting olfactory receptor functions. | ||||||
Metoprolol Tartrate | 56392-17-7 | sc-205751 sc-205751A | 5 g 25 g | $105.00 $238.00 | 3 | |
Metoprolol is a selective beta-1 adrenergic receptor blocker. By targeting these receptors, it can indirectly influence the signaling mechanisms of GPCRs, which may affect the activity of olfactory receptors. | ||||||
Esmolol | 81147-92-4 | sc-279019B sc-279019A sc-279019 | 50 mg 100 mg 500 mg | $100.00 $150.00 $650.00 | 1 | |
Esmolol is a selective beta-1 adrenergic receptor antagonist. Its selective inhibition of these receptors can indirectly modulate GPCR signaling pathways, potentially influencing olfactory receptor function. | ||||||